These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 38958009)
1. Lymphoid organ-targeted nanomaterials for immunomodulation of cancer, inflammation, and beyond. Hsu JC; Liu P; Song Y; Song W; Saladin RJ; Peng Y; Hu S; Lan X; Cai W Chem Soc Rev; 2024 Jul; 53(15):7657-7680. PubMed ID: 38958009 [TBL] [Abstract][Full Text] [Related]
2. Nanomaterials Enhance the Immunomodulatory Effect of Molecular Targeted Therapy. Li Z; Liu Y; Fang X; Shu Z Int J Nanomedicine; 2021; 16():1631-1661. PubMed ID: 33688183 [TBL] [Abstract][Full Text] [Related]
3. Chemical Strategies to Enhance the Therapeutic Efficacy of Toll-like Receptor Agonist Based Cancer Immunotherapy. Lee SN; Jin SM; Shin HS; Lim YT Acc Chem Res; 2020 Oct; 53(10):2081-2093. PubMed ID: 32966047 [TBL] [Abstract][Full Text] [Related]
4. Biomaterials as Local Niches for Immunomodulation. Adu-Berchie K; Mooney DJ Acc Chem Res; 2020 Sep; 53(9):1749-1760. PubMed ID: 32786230 [TBL] [Abstract][Full Text] [Related]
9. Nanomaterials-Based Novel Immune Strategies in Clinical Translation for Cancer Therapy. Wahab S; Ghazwani M; Hani U; Hakami AR; Almehizia AA; Ahmad W; Ahmad MZ; Alam P; Annadurai S Molecules; 2023 Jan; 28(3):. PubMed ID: 36770883 [TBL] [Abstract][Full Text] [Related]
11. Nanomaterial-mediated modulation of the cGAS-STING signaling pathway for enhanced cancer immunotherapy. Wang Y; Liu Y; Zhang J; Peng Q; Wang X; Xiao X; Shi K Acta Biomater; 2024 Mar; 176():51-76. PubMed ID: 38237711 [TBL] [Abstract][Full Text] [Related]
12. Nanomaterials for direct and indirect immunomodulation: A review of applications. Kubackova J; Zbytovska J; Holas O Eur J Pharm Sci; 2020 Jan; 142():105139. PubMed ID: 31704342 [TBL] [Abstract][Full Text] [Related]
13. Fibroblastic reticular cells at the nexus of innate and adaptive immune responses. Perez-Shibayama C; Gil-Cruz C; Ludewig B Immunol Rev; 2019 May; 289(1):31-41. PubMed ID: 30977192 [TBL] [Abstract][Full Text] [Related]
14. Enhancing Cancer Chemo-Immunotherapy: Innovative Approaches for Overcoming Immunosuppression by Functional Nanomaterials. Wang J; Li L; Xu ZP Small Methods; 2024 Jan; 8(1):e2301005. PubMed ID: 37743260 [TBL] [Abstract][Full Text] [Related]
15. Nanomaterials for T-cell cancer immunotherapy. Gong N; Sheppard NC; Billingsley MM; June CH; Mitchell MJ Nat Nanotechnol; 2021 Jan; 16(1):25-36. PubMed ID: 33437036 [TBL] [Abstract][Full Text] [Related]
16. Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: Where do we stand? Yuan CS; Deng ZW; Qin D; Mu YZ; Chen XG; Liu Y Acta Biomater; 2021 Apr; 125():1-28. PubMed ID: 33639310 [TBL] [Abstract][Full Text] [Related]
17. Recent Advances of Emerging Spleen-Targeting Nanovaccines for Immunotherapy. He X; Wang J; Tang Y; Chiang ST; Han T; Chen Q; Qian C; Shen X; Li R; Ai X Adv Healthc Mater; 2023 Sep; 12(23):e2300351. PubMed ID: 37289567 [TBL] [Abstract][Full Text] [Related]
18. Immunological nanomaterials to combat cancer metastasis. Pan Y; Cheng J; Zhu Y; Zhang J; Fan W; Chen X Chem Soc Rev; 2024 Jun; 53(12):6399-6444. PubMed ID: 38745455 [TBL] [Abstract][Full Text] [Related]
19. Biomaterial Strategies for Immunomodulation. Hotaling NA; Tang L; Irvine DJ; Babensee JE Annu Rev Biomed Eng; 2015; 17():317-49. PubMed ID: 26421896 [TBL] [Abstract][Full Text] [Related]
20. Nanoengineered Immune Niches for Reprogramming the Immunosuppressive Tumor Microenvironment and Enhancing Cancer Immunotherapy. Phuengkham H; Ren L; Shin IW; Lim YT Adv Mater; 2019 Aug; 31(34):e1803322. PubMed ID: 30773696 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]